CORVUS PHARMACEUTICALS
8.8000
07-November-24 14:59:59
15 minutes delayed
Stocks
+0.0200
+0.23%
Today's range
8.4300 - 9.1000
ISIN
N/A
Source
NASDAQ
-
Corvus Pharmaceuticals Announces Pricing of $30.6 Million Registered Direct Offering
02 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
09 Apr 2024 15:01:00 By Nasdaq GlobeNewswire
-
19 Mar 2024 15:02:00 By Nasdaq GlobeNewswire
-
13 Mar 2024 15:02:00 By Nasdaq GlobeNewswire
-
12 Feb 2024 07:30:00 By Nasdaq GlobeNewswire
-
08 Feb 2024 15:05:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Appoints Jeffrey Arcara as Chief Business Officer
06 Feb 2024 15:05:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces the Passing of Board Member Edith P. Mitchell
23 Jan 2024 16:00:00 By Nasdaq GlobeNewswire
-
09 Dec 2023 11:00:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results
07 Nov 2023 15:01:00 By Nasdaq GlobeNewswire
-
31 Oct 2023 15:02:00 By Nasdaq GlobeNewswire
-
06 Sep 2023 15:05:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
08 Aug 2023 15:01:00 By Nasdaq GlobeNewswire
-
01 Aug 2023 07:30:00 By Nasdaq GlobeNewswire
-
06 Jul 2023 11:59:15 By Nasdaq GlobeNewswire
-
29 Jun 2023 06:00:00 By Nasdaq GlobeNewswire
-
15 Jun 2023 06:00:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals to Present at the Jefferies Healthcare Conference
31 May 2023 07:30:00 By Nasdaq GlobeNewswire